![]() | |
Names | |
---|---|
IUPAC name
3-[benzoyl(methyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]-2-fluorobenzamide
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.214.739 |
EC Number |
|
KEGG | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C25H14BrF11N2O2 | |
Molar mass | 663.285 g·mol−1 |
Hazards | |
GHS labelling: | |
![]() | |
Warning | |
H410 | |
P273, P391, P501 | |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Broflanilide is a complex, polycyclic, organohalogen insecticide which provides a novel mode of action (MoA).
Upon its discovery by Mitsui Chemicals, Insecticide Resistance Action Committee (IRAC) created the new MoA Group 30 for Broflanilide. [1] [2] [3] [4] Broflanilide is a meta-diamide GABA-gated Cl− channel allosteric modulator. [1] [2] [3] [4] This - along with isoxazolines providing the same MoA, so far only fluxametamide - constitute the new MoA Group 30 in the IRAC classification scheme. [3]
The EPA has stated that Broflanilide is "Likely to be Carcinogenic to Humans". [5]
Broflanilide meets the EPA Working Definition of PFAS. Note that "EPA considers any level of PFAS to be potentially toxicologically significant". [6]
Products were registered in the United States in January, 2021, [7] and in Canada. [1] It is being sold under the brand names Cimegra ( BASF) [8] and Teraxxa (BASF, the seed treatment form). [9]
![]() | |
Names | |
---|---|
IUPAC name
3-[benzoyl(methyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]-2-fluorobenzamide
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.214.739 |
EC Number |
|
KEGG | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C25H14BrF11N2O2 | |
Molar mass | 663.285 g·mol−1 |
Hazards | |
GHS labelling: | |
![]() | |
Warning | |
H410 | |
P273, P391, P501 | |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Broflanilide is a complex, polycyclic, organohalogen insecticide which provides a novel mode of action (MoA).
Upon its discovery by Mitsui Chemicals, Insecticide Resistance Action Committee (IRAC) created the new MoA Group 30 for Broflanilide. [1] [2] [3] [4] Broflanilide is a meta-diamide GABA-gated Cl− channel allosteric modulator. [1] [2] [3] [4] This - along with isoxazolines providing the same MoA, so far only fluxametamide - constitute the new MoA Group 30 in the IRAC classification scheme. [3]
The EPA has stated that Broflanilide is "Likely to be Carcinogenic to Humans". [5]
Broflanilide meets the EPA Working Definition of PFAS. Note that "EPA considers any level of PFAS to be potentially toxicologically significant". [6]
Products were registered in the United States in January, 2021, [7] and in Canada. [1] It is being sold under the brand names Cimegra ( BASF) [8] and Teraxxa (BASF, the seed treatment form). [9]